Within the Central Nervous System Therapeutics Market segment, the market is broadly divided by Therapeutic Area, including Neurodegenerative Diseases (such as Alzheimer's, Parkinson's, and Multiple Sclerosis), Neuropsychiatric Disorders (including depression and schizophrenia), Neurological Disorders (like epilepsy and stroke), Pain Management, and Neuro-Oncology. This diverse segmentation...